# Quantifying the Learning Curve in Ultrasound-Guided Vascular Access: Proficiency Metrics of Self-Taught Axillary Vein Puncture for CIED Implantation

**Authors:** Dimitrios A. Vrachatis, Konstantinos A. Papathanasiou, Ioannis Anagnostopoulos, Sotiria G. Giotaki, Maria Kousta, Christos Karavasilis, Christos Piperis, Panagiotis Tolios, Andreas Kaoukis, Konstantinos Raisakis, Georgios Giannopoulos, Theodore G. Papaioannou, Gerasimos Siasos, Spyridon Deftereos

PMC · DOI: 10.3390/medsci14010115 · 2026-02-27

## TL;DR

This study shows that self-taught ultrasound-guided axillary vein puncture for heart device implantation is safe and effective, with a high success rate.

## Contribution

The study provides real-world data on the learning curve and safety of self-taught ultrasound-guided axillary vein puncture for CIED implantation.

## Key findings

- The success rate of US-guided AVP was 94.2% with no major complications.
- Success rates improved significantly after the first six months of use.
- The technique is feasible for experienced electrophysiologists without formal training.

## Abstract

Background: Ultrasound (US)-guided axillary vein puncture (AVP) is an established technique for cardiac implantable electronic device (CIED) implantation. Yet real-world data concerning shifting from conventional venous access into US-guided AVP are not widely available. Methods: This is a single-center prospective registry reporting safety (complications) and efficacy (success rate: i.e., accomplishment of the vein access utilizing only the initially employed approach) of self-taught US-guided AVP integration into the standard workflow of CIED procedures. Results: A total of 539 patients (mean age 71.5 ± 12.4 years old, 78.7% males) were treated in our institution over a three-year period. Regarding CIED type and lead number, 58.3% used an implantable cardioverter defibrillator, 32% used permanent pacemakers, and two leads were involved in 65.8% of the cases and three leads in 8.9%. Before integration of US-guided AVP, the venous access success rate was 93.5%. The US-guided AVP success rate was 377/400 procedures (94.2%). After the first semester of US-guided AVP utilization, a pattern of increased success rate was observed (p = 0.002) and remained stable over the following semesters. No major complication (periprocedural or 30-day mortality, hemothorax, pneumothorax and tamponade) occurred after US AVP integration in our workflow. Conclusions: The integration of US-guided AVP in a self-taught manner is feasible among electrophysiologists with experience in US-guided vascular access. A high success rate can be reached quickly and safely.

## Full-text entities

- **Diseases:** injury to (MESH:D014947), deaths (MESH:D003643), impaired renal function (MESH:D007674), obese (MESH:D009765), pain (MESH:D010146), pneumothorax (MESH:D011030), inspiratory collapse (MESH:D001261), hemothorax (MESH:D006491), tamponade (MESH:D002305), complication (MESH:D008107), CIED (MESH:D009471), allergies (MESH:D004342)
- **Chemicals:** lidocaine (MESH:D008012), AVP (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13027568/full.md

---
Source: https://tomesphere.com/paper/PMC13027568